Loading this company
Loading this company
Priced within our range of $43.67 to $108.42.
$104.24USD down −$0.65 (−0.62%)
Quoted · Prices are delayed.
Nothing we can cite explains today’s move for this company.
Our range from 4 models, on today’s numbers
$43.67–$108.42
What the price needs: revenue growth of 14.7%/yr for 5 years (our model assumes 6.6%).
Led by discounted cash flow (DCF) · Dividend income business
Price $104.24Priced · Prices are delayed.
Our forward range over 12 months is part of Pro. See plans
Analysts’ mean target
$120.72 across 26 analysts
The high and low of the analyst range is part of Pro. See plans
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. It operates in the Medical Devices industry (Healthcare sector), headquartered in United States. The company employs roughly 122,000 people.
Prices are delayed. The feed does not say when these figures were taken.
No recent headlines we can cite for this company.
No insider filings for this company in the recent window.
Not investment advice. TickerWorth Score is a model output.
The score, the fair value and the reverse DCF are free on every company. Pro lets you change growth, margin and the discount rate yourself, see every valuation lens and its working, and download the model. Start a 7-day free trial — a card is required and you can cancel any time before it ends. $99 a year, or $14.99 monthly.